BIVALIRUDIN FOR INJECTION

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: 7b7288af98f46462
Drug Approval Canada Name: BIVALIRUDIN FOR INJECTION
Product Name: BIVALIRUDIN FOR INJECTION
Status: Marketed
Status Date: 2019-04-23
Original Market Date: 2019-04-23
Din: 02435268
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 20:12.04.12
Atc Original: B01AE06 BIVALIRUDIN
Atc Name: b 01 ae 06
Aig Number: 0148342001
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

BIVALIRUDIN

250 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7b7288af98f46462

Type

Standard